$7.35
Price
$2.7B
Market Cap
—
P/E Ratio
-15.0
Forward P/E
$-2.78
EPS (TTM)
—
Dividend Yield
$226M
Cash
$2M
Total Debt
371M
Shares Out
$3.27
$7.45
52-Week Range
Institutional Ownership of Atai Life Sciences NV
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| 42.1K | $221930 | $3.77 | +92.56% |
Trading Activity for Atai Life Sciences NV
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q1 | |||||
| BUY | NEW | 42.1K | $149076 | $3.77 | |
| 2025-Q4 | |||||
| SELL | EXIT | — | — | $4.36 | |
| 2023-Q1 | |||||
| BUY | NEW | 42.1K | $76223 | $1.74 | |
Insider Trading for Atai Life Sciences NV
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.